Insulin-like growth factors and prostate cancer: A population-based case-control study in china

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 5, 2001, Pages 421-427

  Chokkalingam, Anand P ^a   Pollak, Michael ^b   Fillmore, Capri Mara ^a   Gao, Yu Tang ^c   Stanczyk, Frank Z ^d   Deng, Jie ^c   Sesterhenn, Isabell A ^e   Mostofi, F Kash ^e   Fears, Thomas R ^a   Madigan, M Patricia ^a   Ziegler, Regina G ^a   Fraumeni, Joseph F ^a   Hsing, Ann W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c SHANGHAI CANCER INSTITUTE   (China)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANEDIOL; GLUCURONIDE; MITOGENIC AGENT; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINA; EPITHELIUM CELL; GEOGRAPHIC DISTRIBUTION; GROWTH REGULATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; CASE-CONTROL STUDIES; CHINA; CONFIDENCE INTERVALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; POPULATION SURVEILLANCE; PROBABILITY; PROSTATIC NEOPLASMS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SOMATOMEDINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034916063     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
2. Insulin-like growth factor-I: A key regulator of human cancer risk?
3. Serum insulin-like growth factors and insulin-like growth factor-binding proteins: Clinical implications
4. Insulin-like growth factors and prostate cancer
5. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells
6. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3)
7. Systemic administration of insulin-like growth factor 1 (IGF-I) causes growth of the rat prostate
8. Growth hormone and prostate cancer: Guilty by association?
9. Circulating IGF-1. New perspectives for a new century
10. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism
11. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
12. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
13. Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study
14. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
15. Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer
16. Insulin-like growth factor-binding protein-I and prostate cancer
17. International trends and patterns of prostate cancer incidence and mortality
18. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: A population-based case-control study in China
19. Body size and prostate cancer: A population-based case-control study in Shanghai, China
20. 5α-reductase activity and prostate cancer: A case-control study using stored sera
21. Serum free insulin-like growth factor-I is dose-dependently decreased by methylprednisolone and related to body weight changes in rats
22. Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary
23. Castration-induced apoptosis of androgen-dependent Shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteins
24. Bicalutamide (Casodex)-induced prostate regression involves increased expression of genes encoding insulin-like growth factor binding proteins
25. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: Relation to age, sex, stage of puberty, testicular size, and body mass index
26. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease